间皮瘤;胸膜的临床试验
总计1059个结果
-
Brigham and Women's HospitalDana-Farber Cancer Institute完全的
-
Mayo ClinicNational Cancer Institute (NCI)完全的
-
Polaris Group终止胶质瘤 | 肝细胞癌 | 葡萄膜黑色素瘤 | 肉瘤样癌 | 胸膜间皮瘤恶性晚期 | 腹膜间皮瘤恶性晚期 | 非鳞状非小细胞肺癌美国, 英国
-
University Hospital, AntwerpRoche Pharma AG; Algemeen Ziekenhuis Maria Middelares; Kom Op Tegen Kanker; Vitaz招聘中
-
Targovax OyTheradex未知确定 ONCOS-102 联合化疗的安全性、耐受性和疗效西班牙, 法国
-
Memorial Sloan Kettering Cancer Center招聘中
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)终止复发性非小细胞肺癌 | 复发性胸膜恶性间皮瘤 | III 期胸膜恶性间皮瘤 AJCC v7 | IV 期胸膜恶性间皮瘤 AJCC v7 | IV 期非小细胞肺癌 AJCC v7 | IIIA 期非小细胞肺癌 AJCC v7 | HLA-A*0201 阳性细胞存在 | 晚期胸膜恶性间皮瘤 | III 期非小细胞肺癌 AJCC v7 | IIIB 期非小细胞肺癌 AJCC v7 | WT1 阳性美国
-
Wales Cancer Trials UnitVelindre NHS Trust; June Hancock Mesothelioma Research Fund; Velindre Cancer Centre Stepping Stones...未知
-
University of PennsylvaniaNational Institutes of Health (NIH); Tmunity Therapeutics, a wholly owned subsidiary of Kite...主动,不招人
-
Incyte Corporation撤销晚期和/或转移性实体瘤 | IIIB 期不适合 IV 期非小细胞肺癌的治愈性治疗 | 晚期/转移性不可切除恶性胸膜间皮瘤
-
University Hospital, AntwerpKom Op Tegen Kanker; Stichting tegen Kanker主动,不招人
-
Sellas Life Sciences GroupUnited States Department of Defense完全的
-
Memorial Sloan Kettering Cancer CenterUniversity of Pennsylvania; Dana-Farber Cancer Institute; Novartis Pharmaceuticals完全的
-
Al-Quds UniversityAssiut University; Tanta University; European Institute of Oncology招聘中
-
National Cancer Institute (NCI)终止
-
Southwest Oncology GroupNational Cancer Institute (NCI)完全的
-
AstraZeneca完全的
-
Swiss Group for Clinical Cancer Research主动,不招人
-
Asbestos Diseases Research FoundationEnGeneIC Limited完全的
-
Nevada Cancer Institute终止Non-Small Cell Lung Cancer and Pleural Mesothelioma美国
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)完全的